skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Life Sciences & Biomedicine remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

Zhang, Yanjun ; Zeng, Gang ; Pan, Hongxing ; Li, Changgui ; Hu, Yaling ; Chu, Kai ; Han, Weixiao ; Chen, Zhen ; Tang, Rong ; Yin, Weidong ; Chen, Xin ; Hu, Yuansheng ; Liu, Xiaoyong ; Jiang, Congbing ; Li, Jingxin ; Yang, Minnan ; Song, Yan ; Wang, Xiangxi ; Gao, Qiang ; Zhu, Fengcai

The Lancet infectious diseases, 2021-02, Vol.21 (2), p.181-192 [Periódico revisado por pares]

United States: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial

Han, Bihua ; Song, Yufei ; Li, Changgui ; Yang, Wanqi ; Ma, Qingxia ; Jiang, Zhiwei ; Li, Minjie ; Lian, Xiaojuan ; Jiao, Wenbin ; Wang, Lei ; Shu, Qun ; Wu, Zhiwei ; Zhao, Yuliang ; Li, Qi ; Gao, Qiang

The Lancet infectious diseases, 2021-12, Vol.21 (12), p.1645-1653 [Periódico revisado por pares]

United States: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2
Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2
Material Type:
Artigo 		Adicionar ao Meu Espaço

Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2

Wang, Hui ; Zhang, Yuntao ; Huang, Baoying ; Deng, Wei ; Quan, Yaru ; Wang, Wenling ; Xu, Wenbo ; Zhao, Yuxiu ; Li, Na ; Zhang, Jin ; Liang, Hongyang ; Bao, Linlin ; Xu, Yanfeng ; Ding, Ling ; Zhou, Weimin ; Gao, Hong ; Liu, Jiangning ; Niu, Peihua ; Zhao, Li ; Zhen, Wei ; Fu, Hui ; Yu, Shouzhi ; Zhang, Zhengli ; Xu, Guangxue ; Li, Changgui ; Lou, Zhiyong ; Xu, Miao ; Qin, Chuan ; Wu, Guizhen ; Gao, George Fu ; Tan, Wenjie ; Yang, Xiaoming

Cell, 2020-08, Vol.182 (3), p.713-721.e9 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
4
Safety and immunogenicity of inactivated COVID‐19 vaccine in health care workers
Safety and immunogenicity of inactivated COVID‐19 vaccine in health care workers
Material Type:
Artigo 		Adicionar ao Meu Espaço

Safety and immunogenicity of inactivated COVID‐19 vaccine in health care workers

Benjamanukul, Saovanee ; Traiyan, Sasiwimon ; Yorsaeng, Ritthideach ; Vichaiwattana, Preeyaporn ; Sudhinaraset, Natthinee ; Wanlapakorn, Nasamon ; Poovorawan, Yong

Journal of medical virology, 2022-04, Vol.94 (4), p.1442-1449 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
5
Inactivated Rabies Virus-Based Ebola Vaccine Preserved by Vaporization Is Heat-Stable and Immunogenic Against Ebola and Protects Against Rabies Challenge
Inactivated Rabies Virus-Based Ebola Vaccine Preserved by Vaporization Is Heat-Stable and Immunogenic Against Ebola and Protects Against Rabies Challenge
Material Type:
Artigo 		Adicionar ao Meu Espaço

Inactivated Rabies Virus-Based Ebola Vaccine Preserved by Vaporization Is Heat-Stable and Immunogenic Against Ebola and Protects Against Rabies Challenge

Kurup, Drishya ; Fisher, Christine R ; Smith, Todd G ; Abreu-Mota, Tiago ; Yang, Yong ; Jackson, Felix R ; Gallardo-Romero, Nadia ; Franka, Richard ; Bronshtein, Victor ; Schnell, Matthias J

The Journal of infectious diseases, 2019-11, Vol.220 (9), p.1521-1528 [Periódico revisado por pares]

United States: Oxford University Press

Texto completo disponível

Citações Citado por
6
Influenza vaccine for chronic obstructive pulmonary disease (COPD)
Influenza vaccine for chronic obstructive pulmonary disease (COPD)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Influenza vaccine for chronic obstructive pulmonary disease (COPD)

Kopsaftis, Zoe ; Wood‐Baker, Richard ; Poole, Phillippa ; Poole, Phillippa

Cochrane database of systematic reviews, 2018-06, Vol.2018 (6), p.CD002733 [Periódico revisado por pares]

Chichester, UK: John Wiley & Sons, Ltd

Texto completo disponível

Citações Citado por
7
Effects of Newcastle disease virus vaccine antibodies on the shedding and transmission of challenge viruses
Effects of Newcastle disease virus vaccine antibodies on the shedding and transmission of challenge viruses
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effects of Newcastle disease virus vaccine antibodies on the shedding and transmission of challenge viruses

Miller, Patti J. ; Afonso, Claudio L. ; El Attrache, John ; Dorsey, Kristi M. ; Courtney, Sean C. ; Guo, Zijing ; Kapczynski, Darrell R.

Developmental and comparative immunology, 2013-12, Vol.41 (4), p.505-513 [Periódico revisado por pares]

United States: Elsevier Ltd

Texto completo disponível

Citações Citado por
8
Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial
Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial

Xia, ShengLi ; Zhang, YunTao ; Wang, YanXia ; Wang, Hui ; Yang, YunKai ; Gao, George Fu ; Tan, WenJie ; Wu, GuiZhen ; Xu, Miao ; Lou, ZhiYong ; Huang, WeiJin ; Xu, WenBo ; Huang, BaoYing ; Wang, Wei ; Zhang, Wei ; Li, Na ; Xie, ZhiQiang ; Zhu, Xiujuan ; Ding, Ling ; You, WangYang ; Zhao, YuXiu ; Zhao, Jun ; Huang, LiLi ; Shi, XueZhong ; Yang, YongLi ; Xu, GuangXue ; Wang, WenLing ; Liu, PeiPei ; Ma, Meng ; Qiao, YuLing ; Zhao, SuHua ; Chai, JingJing ; Li, QinQin ; Fu, Hui ; Xu, Ying ; Zheng, XiaoTong ; Guo, WanShen ; Yang, XiaoMing

The Lancet infectious diseases, 2022-02, Vol.22 (2), p.196-208 [Periódico revisado por pares]

United States: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial

Ella, Raches ; Reddy, Siddharth ; Jogdand, Harsh ; Sarangi, Vamshi ; Ganneru, Brunda ; Prasad, Sai ; Das, Dipankar ; Raju, Dugyala ; Praturi, Usha ; Sapkal, Gajanan ; Yadav, Pragya ; Reddy, Prabhakar ; Verma, Savita ; Singh, Chandramani ; Redkar, Sagar Vivek ; Gillurkar, Chandra Sekhar ; Kushwaha, Jitendra Singh ; Mohapatra, Satyajit ; Bhate, Amit ; Rai, Sanjay ; Panda, Samiran ; Abraham, Priya ; Gupta, Nivedita ; Ella, Krishna ; Bhargava, Balram ; Vadrevu, Krishna Mohan

The Lancet infectious diseases, 2021-07, Vol.21 (7), p.950-961 [Periódico revisado por pares]

United States: Elsevier Ltd

Texto completo disponível

Citações Citado por
10
Comparative Effectiveness of mRNA and Inactivated Whole-Virus Vaccines Against Coronavirus Disease 2019 Infection and Severe Disease in Singapore
Comparative Effectiveness of mRNA and Inactivated Whole-Virus Vaccines Against Coronavirus Disease 2019 Infection and Severe Disease in Singapore
Material Type:
Artigo 		Adicionar ao Meu Espaço

Comparative Effectiveness of mRNA and Inactivated Whole-Virus Vaccines Against Coronavirus Disease 2019 Infection and Severe Disease in Singapore

Premikha, M ; Chiew, Calvin J ; Wei, Wycliffe E ; Leo, Yee Sin ; Ong, Benjamin ; Lye, David Chien ; Lee, Vernon J ; Tan, Kelvin Bryan

Clinical infectious diseases, 2022-10, Vol.75 (8), p.1442-1445 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (6.529)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (6.725)
  2. Book Chapters  (12)
  3. magazinearticle  (2)
  4. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1965  (66)
  2. 1965Até1978  (125)
  3. 1979Até1992  (471)
  4. 1993Até2007  (1.740)
  5. Após 2007  (4.343)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (6.712)
  2. Japonês  (594)
  3. Português  (37)
  4. Espanhol  (14)
  5. Francês  (13)
  6. Russo  (10)
  7. Alemão  (7)
  8. Italiano  (2)
  9. Norueguês  (2)
  10. Chinês  (2)
  11. Turco  (1)
  12. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.